BARUCH SAMUEL BLUMBERG
Medical Practice in Philadelphia, PA

License number

Pennsylvania MD007663E

Personal information

See more information about BARUCH SAMUEL BLUMBERG at radaris.com

Name

Address

Phone

Baruch J Blumberg, age 99

323 Lawrence Ct, Philadelphia, PA 19106

(215) 925-4519

Baruch J Blumberg, age 99

7701 Burholme Ave, Philadelphia, PA 19111

Baruch S Blumberg

220 Locust St, Philadelphia, PA 19106

Professional information

See more information about BARUCH SAMUEL BLUMBERG at trustoria.com

Senior Advisor At Fox Chase Cancer Center

Position:

Senior Advisor at Fox Chase Cancer Center

Location:

Greater Philadelphia Area

Industry:

Hospital & Health Care

Work:

Fox Chase Cancer Center - Senior Advisor

Inhibition Of Membrane-Associated Viral Replication

US Patent:

6465487, Oct 15, 2002

Filed:

Dec 10, 1998

Appl. No.:

09/209033

Inventors:

Timothy M. Block - Doylestown PA
Raymond A. Dwek - North Hinskey, GB
Baruch S. Blumberg - Philadelphia PA
Anand Mehta - Landenberg PA
Frances Platt - Long Hanborough, GB
Terry D. Butters - Garsington, GB
Nicole Zitzmann - Odendorf, DE

Assignee:

Synergy Pharmaceuticals, Inc. - Somerset NJ
Thomas Jefferson University - Philadelphia PA
The Chancellor, Masters and Scholars of the University of Oxford - Oxford

International Classification:

A61K 31445

US Classification:

514315, 514317, 514326, 514327, 514328

Abstract:

Methods for inhibiting morphogenesis of host cell membrane-budding viruses and infections caused thereby using compounds that inhibit host cell glucosidase or glucosyltransferase enzymes. Methods for treating lipid storage diseases using compounds that inhibit glucosyl transferance enzymes.

Hepatitis B Testing Reagent And Method

US Patent:

4189464, Feb 19, 1980

Filed:

May 5, 1978

Appl. No.:

5/903238

Inventors:

Baruch S. Blumberg - Philadelphia PA
Irving Millman - Willow Grove PA

Assignee:

Institute for Cancer Research - Philadelphia PA

International Classification:

G01N 3316, A61K 4300, G21H 502

US Classification:

424 1

Abstract:

A test reagent reagent for HB. sub. s A. sub. g is prepared by applying to a suitable substrate, such as a polystyrene bead, a first coat of purified HB. sub. s A. sub. g to an extent which will permit complete coverage by anti-HB. sub. s. After washing HB. sub. s A. sub. g coated substrate, serum containing anti-HB. sub. s, or an IgG fraction of serum containing anti-HB. sub. s, is applied as a second coat as a second coat in an amount which substantially completely occupies the reacting sites of the HB. sub. s A. sub. g on the outside of the substrate and leaves an excess of antibody reacting groups in a free state, and any unattached material is washed off. A test sample which is to be tested for HB. sub. s A. sub. g is then contacted with the reagent thus produced, permitting attachment of HB. sub. s A. sub. g if present, and washing is done.

Composition, Pharmaceutical Preparation And Method For Treating Viral Hepatitus

US Patent:

4673575, Jun 16, 1987

Filed:

Apr 26, 1985

Appl. No.:

6/727452

Inventors:

Pinayur S. Venkateswaran - Chester PA
Irving Millman - Willow Grove PA
Baruch S. Blumberg - Philadelphia PA

Assignee:

Fox Chase Cancer Center - Philadelphia PA

International Classification:

A61K 3578

US Classification:

4241951

Abstract:

A pharmaceutical preparation comprising the methanol extractable components of Phyllanthus niruri L. is administered to patients suffering from hepatitis B virus infection in an amount effective for inhibiting the growth of said virus.

Method Of Inhibiting Hepatitis B Virus

US Patent:

6037351, Mar 14, 2000

Filed:

Jul 11, 1996

Appl. No.:

8/676153

Inventors:

Timothy M. Block - Jenkintown PA
Baruch S. Blumberg - Philadelphia PA
Raymond A. Dwek - Oxford, GB

Assignee:

G. D. Searle & Co. - Chicago IL

International Classification:

A61K 31445

US Classification:

514315

Abstract:

A method is disclosed for the treatment of hepatitis B virus (HBV) infections which comprises administering to the infected host an N-alkyl derivative of 1,5-dideoxy-1,5-imino-D-glucitol in which the alkyl group contains from 3 to 6 carbon atoms.